Processa Pharmaceuticals (PCSA) Common Equity (2012 - 2026)
Processa Pharmaceuticals (PCSA) posted Common Equity of -$317,341 for Q2 2026, compared with $6.11 million a year earlier.
Powered by 
Analysis
Processa Pharmaceuticals (PCSA) Common Equity (2012 - 2026) Analysis & Trends
At the end of FY2025, Processa Pharmaceuticals' Common Equity came in at $5.58 million, up 228.8% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -24.6% (FY2020 to FY2025).
- In prior years, Processa Pharmaceuticals' Common Equity was $1.7 million in FY2024 (-66.0%), $4.99 million in FY2023 (-33.2%), $7.47 million in FY2022 (-70.7%) and $25.49 million in FY2021 (+11.1%).
- The Q2 2026 figure stands as the lowest quarterly Common Equity since Q2 2017.
- On a year-over-year basis, Common Equity increased in three of the last seven quarters, with growth averaging 12.1%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q3 2021, with growth of 392.3%; the weakest was Q4 2022, with a decline of 70.7%.
- According to Business Quant data, Common Equity for the three prior quarters was $2.54 million (Q1 2026), $5.58 million (Q4 2025) and $5.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Processa Pharmaceuticals | 5.14 Mn | 5.14 Mn | - | -317,341.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -317,341.00 |
| Mar 31, 2026 | 2.54 Mn |
| Dec 31, 2025 | 5.58 Mn |
| Sep 30, 2025 | 5.83 Mn |
| Jun 30, 2025 | 6.11 Mn |
| Mar 31, 2025 | 3.53 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 3.72 Mn |
| Jun 30, 2024 | 6.02 Mn |
| Mar 31, 2024 | 8.88 Mn |
| Dec 31, 2023 | 4.99 Mn |
| Sep 30, 2023 | 7.17 Mn |
| Jun 30, 2023 | 9.16 Mn |
| Mar 31, 2023 | 10.14 Mn |
| Dec 31, 2022 | 7.47 Mn |
| Sep 30, 2022 | 17.24 Mn |
| Jun 30, 2022 | 20.08 Mn |
| Mar 31, 2022 | 23.24 Mn |
| Dec 31, 2021 | 25.49 Mn |
| Sep 30, 2021 | 27.21 Mn |
API Access
Processa Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PCSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PCSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PCSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();